Biotechnology Should Have Preferred Regulatory Pathways to Catalyze The Bioscience Revolution
CIOREVIEW >> Pharma & life sciences >> NEWS

Novozymes

Lone Dybdal Nilsson, VP of Applied Research in Agriculture and Industrial Bioprocessing

Biotechnology Should Have Preferred Regulatory Pathways to Catalyze The Bioscience Revolution

Lone Dybdal Nilsson, VP of Applied Research in Agriculture and Industrial Bioprocessing
Lone Dybdal Nilsson, VP of Applied Research in Agriculture and Industrial Bioprocessing, Novozymes

Using the tools of nature to unleash the power of nature is a strong path for providing biological answers for better lives in a growing world and addressing the sustainability challenges we are facing. Nevertheless, greater regulatory certainty for new biologic products for farming is needed to bring biosolutions to bear.

In nature, microorganisms mutate and exchange genetic information continuously to adapt to the challenges they face while surviving in their changing environments. Such continuous adaptation can serve to improve capabilities like the utilization of new sources of nutrition or the ability to overcome threats from other microorganisms.

With modern sequencing technology, microbial genomes and any small alteration can be mapped with extreme accuracy, enabling highly specific alteration of microbial genomes. In the past decades, methods for specific and controlled modification of genetic information in microorganisms have been employed with an increasing focus on their role in unlocking sustainability using bioscience solutions.

U.S. regulations must be updated to fully leverage biotechnologies for a better world.

For example, CRISPR-Cas techniques for gene editing have been implemented in many laboratories around the world. These are tools that microorganisms also apply in nature, but in some regulatory schemes, they are subject to extreme scrutiny in an approval process that is not clear or aligned between agencies. This is done to a degree that is limiting access to the benefits of transformative climate-smart solutions for farmers and consumers.

Gene editing tools are highly effective for removing genes that could lead to the expression of harmful metabolites or incur inappropriate resistance in an organism (e.g., antibiotic resistance genes). They are also useful for enhancing a microorganism’s expression of compounds that it already expresses to grow and defend itself in nature (e.g., enzymes), or adding beneficial capabilities from other microorganisms, leading to higher efficacy in the application.

With such techniques, controlled modification of microorganisms can be used to strengthen the beneficial impact of biological solutions. This includes addressing societal needs like breaking down waste material (for recycling and less landfill) or strengthening the gut health of a chicken or the nutrition uptake of a corn plant (to increase production yield and reduce the use of antibiotics and chemical pesticides in the food chain). In other words, it is possible to accelerate an otherwise slow genetic evolution of microorganisms for the benefit of human health and our planet.

With modern sequencing technology, microbial genomes and any small alteration can be mapped with extreme accuracy, enabling highly specific alteration of microbial genomes. Our world needs all the help it can get. We strongly support efforts to update the regulatory framework for genetically modified microorganisms across all sectors. Regulatory uncertainty stymies industry innovation. However, the reverse–a nimble, fact-based approach– enables the government to be a full and agile partner that is able to take advantage of emergent, beneficial, and safe biotechnological solutions to address global challenges.

Only with a progressive and science-based regulatory framework and a framework that is consistent between the main agencies with authority on agriculture (USDA, FDA, EPA) can the U.S. fully deploy the opportunities of biotechnology.

Let’s demystify genetic evolution and make the world a better place sustainably.

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.